Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology

Brain Research

Volumn 1193, Issue , 2008, Pages 67-75

  Fenney, Alison ^a   Jog, Mandar S ^b   Duval, Christian ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Basal ganglia; Chorea; Dyskinesia; Huntington; Kinetic; Parkinson; Whole body involuntary movement

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; BRADYKINESIA; CLINICAL ARTICLE; CORPUS STRIATUM; FEMALE; GLOBUS PALLIDUS; HUMAN; HUNTINGTON CHOREA; INVOLUNTARY MOVEMENT; MALE; MOTOR PERFORMANCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; TASK PERFORMANCE;

ADULT; AGED; BASAL GANGLIA; FEMALE; HUMANS; HUNTINGTON DISEASE; HYPOKINESIA; MALE; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE;

EID: 39149140385     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.12.005     Document Type: Article

References (49)

1. Agostino R., Berardelli A., Formica A., Accornero N., and Manfredi M. Sequential arm movements in patients with Parkinson's disease, Huntington's disease and dystonia. Brain 115 (1992) 1481-1495
2. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12 10 (1989) 366-375
3. Albin R.L., Reiner A., Anderson K.D., Penney J.B., and Young A.B. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-a-kinesia. Ann. Neurol. 27 (1990) 357-365
4. Alexander G.E., Delong M.R., and Strick P.I. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9 (1986) 357-381
5. Aron A.R., and Poldrack R.A. Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus. J. Neurosci. 26 9 (2006) 2424-2433
6. Berardelli A., Noth J., Thompson P.D., Bollen E.L.M., Curra A., Deuschl G., van Dijk G., Töpper R., Schwarz M., and Roos R.A.C. Review: pathophysiology of chorea and bradykinesia in Huntington's disease. Mov. Disord. 14 3 (1999) 398-403
7. Beuter A., de Geoffroy A., and Edwards R. Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits. Environ. Res. 80 1 (1999) 64-79
8. Bilney B., Morris M.E., and Perry A. Effectiveness of physiotherapy, occupational therapy, and speech pathology for people with Huntington's disease: a systematic review. Neurorehab. Neural. Repair 17 1 (2003) 12-24
9. Bilney B., Morris M.E., Churchyard A., Chiu E., and Georgiou-Karistianis N. Evidence for a disorder of locomotor timing in Huntington's disease. Mov. Disord. 20 1 (2005) 51-57
10. Bonelli R.M., Wenning G.K., and Kapfhammer H.P. Huntington's disease: present treatments and future therapeutic modalities. Int. Clin. Psychopharmacol. 19 (2004) 51-62
11. Boulet C., Lemay M., Bédard M.A., Chouinard M.J., Chouinard J., and Richer F. Early Huntington's disease affects movements in transformed sensorimotor mappings. Brain Cogn. 57 (2005) 236-243
12. Cunnington R., Windischberger C., Deecke L., and Moser E. The preparation and execution of self-initiated and externally-triggered movement: a study of event-related fMRI. NeuroImage 15 2 (2000) 373-385
13. Crossman A.R., Mitchell I.J., Sambrook M.A., and Jackson A. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. Brain 111 (1988) 1211-1233
14. Curra A., Agostino R., Galizia P., Fittipaldi F., Manfredi M., and Berardelli A. Sub-movement cueing and motor sequence execution in patients with Huntington's disease. Clin. Neurophysiol. 111 (2000) 1184-1190
15. Duval C., Panisset M., and Sadikot A.F. The relationship between physiological tremor and the performance of rapid alternating movements in healthy elderly subjects. Exp. Brain Res. 139 (2001) 412-418
16. Duval C., Sadikot A.F., and Panisset M. Bradykinesia in patients with essential tremor. Brain Res. 1115 1 (2006) 213-216
17. Duval C., Panisset M., Strafella A.P., and Sadikot A.F. The impact of ventrolateral thalamotomy on tremor and voluntary motor behavior of patient with Parkinson's disease. Exp. Brain Res. 170 2 (2006) 160-171
18. Fenney, A., Jog, M.S., Duval, C., in press. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea. Clin. Neurol. Neurosurg.
19. Fimbel E.J., Domingo P.P., Lamoureux D., and Beuter A. Automatic detection of movement disorders using recordings of rapid alternating movements. J. Neurosci. Methods 146 2 (2005) 183-190
20. Garcia-Ruiz P.J., Hernandex J., Cantarero S., Bartolome M., Bernardos V.S., and de Yebenes J.G. Bradykinesia in Huntington's disease: a prospective follow up study. J. Neurol. 249 (2002) 437-440
21. Gardian G., and Vecsei L. Huntington's disease: pathomechanism and therapeutic perspectives. J. Neural Transm. 111 (2004) 1485-1494
22. Ghassemi M., Lemieux S., Jog M., Edwards R., and Duval C. Levadopa-induced dyskinesias and bradykinesia in patients with Parkinson's disease. Brain Res. Bull. 69 5 (2006) 512-518
23. Gour J., Edwards R., Lemieux S., Ghassemi M., Jog M., and Duval C. Movement patterns of levodopa-induced dyskinesias in patients with Parkinson's disease. Brain Res. Bull. 74 (2007) 66-74
24. Hamilton J.M., Salmon D.P., Corey-Bloom J., Gamst A., Paulsen J.S., Jerkins S., Jacobsen M.W., and Peavy G. Behavioral abnormalities contribute to functional decline in Huntington's disease. J. Neurol. Neurosurg. Psychiatry 74 (2003) 120-122
25. Hashimoto T., Shindo M., and Yanagisawa N. Enhanced associated movements in the contralateral limbs elicited by brisk voluntary contraction in choreic disorders. Clin. Neurophysiol. 112 (2001) 1612-1617
26. Hedreen J.C., and Folstein S.E. Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 54 (1994) 105-120
27. Hefter H., Homberg V., Lange H.W., and Freund H.J. Impairment of rapid movement in Huntington's disease. Brain 110 (1987) 585-612
28. Jackson A., and Crossman A.R. Experimental choreoathetosis produced by injection of a gamma-aminobutyric acid antagonist into the lentiform nucleus in the monkey. Neurosci. Lett. 46 (1984) 41-45
29. Jahanshahi M., Brown R.G., and Marsden C.D. A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease. J. Neurol. Neurosurg. Psychiatry 56 11 (1993) 1169-1177
30. Joel D. Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease. Mov. Disord. 16 3 (2001) 407-423
31. Kim J.S., Reading S.A.J., Brashers-Krug T., Calhoun V.D., Ross C.A., and Pearlson G.D. Functional MRI study of a serial reaction time task in Huntington's disease. Psychiatr. Res. Neuroimaging 131 (2004) 23-30
32. Lemay M., Fimbel E., Beuter A., Chouinard S., and Richer F. Sensorimotor mapping affects movement correction deficits in early Huntington's disease. Exp. Brain Res. 165 4 (2005) 454-460
33. Lemieux S., Ghassemi M., Jog M., Edwards R., and Duval C. The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease. Exp. Brain Res. 176 3 (2007) 465-475
34. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol. 50 4 (1996) 381-425
35. Mink J.W. The basal ganglia and voluntary movements. Impaired inhibition of competing motor patterns. Arch. Neurol. 60 10 (2003) 1365-1368
36. Mitchell J., Jackson A., Sambrook M.A., and Crossman A.R. The role of subthalamic nucleus in experimental chorea. Evidence from 2-deoxyglucose metabolic mapping and horseradish peroxidase tracing studies. Brain 112 (1989) 1533-1548
37. Nambu A., Tokuno H., and Takada M. Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway. Neurosci. Res. 43 2 (2002) 111-117
38. Okada M., and Okada M. A method for quantification of alternate pronation and supination of forearms. Comput. Biomed. Res. 16 (1983) 59-68
39. Phillips J.G., Bradshaw J.L., Chui E., Teasdale N., Iansek R., and Bradshaw J.A. Bradykinesia and movement precision in Huntington's disease. Neuropsychologia 34 12 (1996) 1241-1245
40. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., and Young A.B. Differential loss of striatal projection neurons in Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 5733-5737
41. Saft C., Andrich J., Meisel M.N., Przuntek M., and Muller T. Assessment of complex movements reflects dysfunction in Huntington's disease. J. Neurol. 250 (2003) 1469-1474
42. Thompson P.D., Berardelli A., Rothwell J.C., Day B.L., Dick J.P.R., Benecke R., and Marsden C.D. The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. Brain 111 (1988) 223-244
43. Turner R.S., Grafton S.T., Votaw J.R., Delong M.R., and Hoffman J.M. Motor subcircuits mediating the control of movement velocity: a PET study. J. Neurophysiol. 80 4 (1998) 2162-2176
44. Turner R.S., Desmurget M., Grethe J., Crutcher M.D., and Grafton S.T. Motor subcircuits mediating the control of movement extent and speed. J. Neurophysiol. 90 6 (2003) 3958-3966
45. Sharp A.H., and Ross C.A. Neurobiology of Huntington's disease. Neurobiol. Dis. 3 (1996) 3-15
46. van Vugt J.P.P., Stijl M., Roos R.A.C., and van Dijk J.G. Impaired antagonist inhibition may contribute to akinesia and bradykinesia in Huntington's disease. Clin. Neurophysiol. 114 (2003) 295-305
47. van Vugt J.P.P., Piet K.K.E., Vink L.J., Siesling S., Zwinderman A.H., Middelkoop H.A.M., and Roos R.A.C. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2nd year follow up. Mov. Disord. 19 (2004) 285-297
48. Verbessem P., Eijnde B.O., Swinnen S.P., Vangheluwe S., Hespel P., and Dom R. Unimanual and bimanual voluntary movement in Huntington's disease. Exp. Brain Res. 147 (2002) 529-537
49. Weeks R.A., Ceballos-Baumann A., Piccini P., Boecker H., Harding A.E., and Brooks D.J. Cortical control of movement in Huntington's disease. A PET activation study. Brain 120 (1997) 1569-1578